Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
SAB Biotherapeutics
(SABSW) Q2 2024
Earnings
SABSW
May 20
Confirmed
Mar 2021
Jun 2021
Sep 2021
Q2 2024
-0.96
-0.64
-0.32
0
Details
Expected EPS
-0.96
Actual EPS
-0.54
Surprise EPS
0.42
Surprise Percent
+43.75%
Description
SAB Biotherapeutics (SABSW) has reported earnings of -0.54 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login